Long-term prehypertension treatment with losartan effectively prevents brain damage and stroke in stroke-prone spontaneously hypertensive rats

International Journal of Molecular Medicine

Volumn 33, Issue 2, 2014, Pages 301-309

  He, De Hua ^a,b   Zhang, Liang Min ^b   Lin, Li Ming ^c   Ning, Ruo Bing ^b   Wang, Hua Jun ^d   Xu, Chang Sheng ^d   Lin, Jin Xiu ^b  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c Affiliated Hospital of Putian College   (China)

^d Fujian Hypertension Institute   (China)

Author keywords

Amlodipine; Losartan; Prehypertension; Stroke prone spontaneously hypertensive rats

Indexed keywords

ALDOSTERONE; AMLODIPINE; ANGIOTENSIN II; ANIMALS; APOPTOSIS; BLOOD PRESSURE; BRAIN; HYPERTENSION; LOSARTAN; MALE; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; OXIDATIVE STRESS; PREHYPERTENSION; RATS; RATS, INBRED SHR; RENIN-ANGIOTENSIN SYSTEM; STROKE; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 84893721564     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1583     Document Type: Article

References (34)

1. Chobanian AV, Bakris GL, Black HR, et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289: 2560-2572, 2003.
2. Chobanian AV, Bakris GL, Black HR, et al: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206-1252, 2003.
3. Sun Z, Zheng L, Detrano R, et al: Risk of progression to hypertension in a rural Chinese women population with prehypertension and normal blood pressure. Am J Hypertens 23: 627-632, 2010.
4. Vasan RS, Larson MG, Leip EP, Kannel WB and Levy D: Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: A cohort study. Lancet 358: 1682-1686, 2001.
5. Greenlund KJ, Croft JB and Mensah GA: Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med 164: 2113-2118, 2004.
6. Mainous AG, Everett CJ, Liszka H, King DE and Egan BM: Prehypertension and mortality in a nationally representative cohort. Am J Cardiol 94: 1496-1500, 2004.
7. Maillard P, Seshadri S, Beiser A, et al: Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: A cross-sectional study. Lancet Neurol 11: 1039-1047, 2012.
8. Julius S, Nesbitt SD, Egan BM, et al: Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 354: 1685-1697, 2006.
9. Yambe M, Tomiyama H, Yamada J, et al: Arterial stiffness and progression to hypertension in Japanese male subjects with high normal blood pressure. J Hypertens 25: 87-93, 2007.
10. Baumann M, Janssen BJ, Hermans JJ, et al: Transient AT1 receptor-inhibition in prehypertensive spontaneously hyperten-sive rats results in maintained cardiac protection until advanced age. J Hypertens 25: 207-215, 2007.
11. Peng F, Lin J, Lin L and Tang H: Transient prehypertensive treatment in spontaneously hypertensive rats: A comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection. Int J Mol Med 30: 1376-1386, 2012.
12. Vacher E, Richer C and Giudicelli JF: Effects of losartan on cerebral arteries in stroke-prone spontaneously hypertensive rats. J Hypertens 14: 1341-1348, 1996.
13. Yamori Y, Horie R, Akiguchi I, Kihara M, Nara Y and Lovenberg W: Symptomatological classification in the development of stroke in stroke-prone spontaneously hypertensive rats. Jpn Circ J 46: 274-283, 1982.
14. Wu Y and Song W: Regulation of RCAN1 translation and its role in oxidative stress-induced apoptosis. FASEB J 27: 208-221, 2013.
15. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H and Takeshita A: Increased reactive oxygen species in rostral ventro-lateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 109: 2357-2362, 2004.
16. Ito H, Torii M and Suzuki T: A comparative study on lipid peroxidation in cerebral cortex of stroke-prone spontaneously hypertensive and normotensive rats. Int J Biochem 25: 1801-1805, 1993.
17. Yu L, Quinn MT, Cross AR and Dinauer MC: Gp91(phox) is the heme binding subunit of the superoxide-generating NADPH oxidase. Proc Natl Acad Sci USA 95: 7993-7998, 1998.
18. Tang J, Liu J, Zhou C, et al: Role of NADPH oxidase in the brain injury of intracerebral hemorrhage. J Neurochem 94: 1342-1350, 2005.
19. Fujii J and Taniguchi N: Down regulation of superoxide dismutases and glutathione peroxidase by reactive oxygen and nitrogen species. Free Radic Res 31: 301-308, 1999.
20. Phillips MI and de Oliveira EM: Brain renin angiotensin in disease. J Mol Med (Berl) 86: 715-722, 2008.
21. Wright JW and Harding JW: The brain renin-angiotensin system: A diversity of functions and implications for CNS diseases. Pflugers Arch 465: 133-151, 2013.
22. Gao L, Wang WZ, Wang W and Zucker IH: Imbalance of angiotensin type 1 receptor and angiotensin II type 2 receptor in the rostral ventrolateral medulla: Potential mechanism for sympathetic overactivity in heart failure. Hypertension 52: 708-714, 2008.
23. Takeda-Matsubara Y, Matsubara K, Ochi H, Ito M, Iwai M and Horiuchi M: Expression of endothelial angiotensin II receptor mRNA in pregnancy-induced hypertension. Am J Hypertens 16: 993-999, 2003.
24. Ganten D, Marquez-Julio A, Granger P, et al: Renin in dog brain. Am J Physiol 221: 1733-1737, 1971.
25. Fischer-Ferraro C, Nahmod VE, Goldstein DJ and Finkielman S: Angiotensin and renin in rat and dog brain. J Exp Med 133: 353-361, 1971.
26. Hamaguchi R, Takemori K, Inoue T, Masuno K and Ito H: Short-term treatment of stroke-prone spontaneously hypertensive rats with an AT1 receptor blocker protects against hypertensive end-organ damage by prolonged inhibition of the renin-angiotensin system. Clin Exp Pharmacol Physiol 35: 1151-1155, 2008.
27. Takemori K, Ishida H and Ito H: Continuous inhibition of the renin-angiotensin system and protection from hypertensive end-organ damage by brief treatment with angiotensin II type 1 receptor blocker in stroke-prone spontaneously hypertensive rats. Life Sci 77: 2233-2245, 2005.
28. Ichiki T: Regulation of angiotensin II receptor expression. Curr Pharm Des 19: 3013-3021, 2013.
29. Mogi M and Horiuchi M: Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases. Geriatr Gerontol Int 13: 13-18, 2013.
30. Steckelings UM, Paulis L, Namsolleck P and Unger T: AT2 receptor agonists: Hypertension and beyond. Curr Opin Nephrol Hypertens 21: 142-146, 2012.
31. Muradian K and Schachtschabel DO: The role of apoptosis in aging and age-related disease: Update. Z Gerontol Geriatr 34: 441-446, 2001.
32. Mattson MP: Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 1: 120-129, 2000.
33. Hamet P, Richard L, Dam TV, et al: Apoptosis in target organs of hypertension. Hypertension 26: 642-648, 1995.
34. Kannan K and Jain SK: Oxidative stress and apoptosis. Pathophysiology 7: 153-163, 2000.